Thursday, April 30, 2009 from 2:00 PM - 5:45 PM (ET)
New England is home to a dazzling array of today's most successful biotech inventors, companies, and technologies. But who are the innovators who will help perpetuate our region's global lead in life sciences in the years and decades to come? What are the local innovations that will help transform the way we treat and prevent disease? Through case studies, panel discussion, a keynote chat, and networking sessions, Xconomy will bring to the forefront New England's newest generation of biotech entrepreneurs and startups, as well as the region's most bleeding-edge developments from Big Biotech.
Confirmed speakers include:
James C. Mullen, President and CEO, Biogen Idec
Walter Gilbert, General Partner, BioVentures Investors, and University Professor Emeritus, Harvard
George Church, Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School
Thomas Hughes, President and CEO, Zafgen
Maria Rupnick, Co-Founder, Zafgen, and Instructor of Medicine, Harvard Medical School
Steven Tregay, Founder, President, and CEO, Forma Therapeutics
Peter Hecht, CEO, Ironwood Pharmaceuticals
Tillman Gerngross, Co-founder and scientific advisory board chair, GlycoFi, Co-founder and CEO, Adimab, and Professor of Engineering, Dartmouth
James Collins, University Professor and Professor of Biomedical Engineering, Boston University
Michelle Dipp, Vice President and Head of the U.S. Centre of Excellence for External Drug Discovery, GlaxoSmithKline
Gilmore N. O'Neill, Senior Director, Experimental Neurology, Biogen Idec
Sam Wadsworth, Group Vice President of Translational Research, Genzyme
Eric Olson, VP of Program and Portfolio Management, Vertex Pharmaceuticals
Schedule:
Registration: 1:30 – 2:00 pm
Program: 2:00 – 5:45 pm
Networking reception: 5:45 – 7:00 pm
Ticket information:
Tickets at the door – $395.00
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.
EVENT HOST
EVENT SPONSORS



EVENT PARTNERS


UNDERWRITERS
Alexandria Real Estate Equities • Biogen Idec • EMC • Invest Northern Ireland
J. Robert Scott Executive Search • Jones Lang LaSalle
Science and Technology Directorate, U.S. Department of Homeland Security
Sun Microsystems • UK Trade & Investment • WilmerHale
VENTURE CAPITAL MEMBERS
Advanced Technology Ventures • Atlas Venture • Avalon Ventures
Charles River Ventures • Flagship Ventures
Flybridge Capital Partners • North Bridge Venture Partners • Polaris Venture Partners